The Ess1 prolyl isomerase: Traffic cop of the RNA polymerase II transcription cycle

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 4, 2014, Pages 316-333

  Hanes, Steven D ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

CTD code; Ess1 Pin1; Peptidyl prolyl cis trans isomerase; Saccharomyces cerevisiae; Transcription regulation

Indexed keywords

MESSENGER RNA; PEPTIDYLPROLYL ISOMERASE PIN1; RNA POLYMERASE II; UNTRANSLATED RNA;

BINDING COMPETITION; CHROMATIN; CIS TRANS ISOMERISM; ENZYME SPECIFICITY; ENZYME STRUCTURE; EUKARYOTE; GENE LOCATION; GENE REPRESSION; HUMAN; ISOMERIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REVIEW; RNA PROCESSING; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; TEMPERATURE SENSITIVE MUTANT; TRANSCRIPTION ELONGATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

CTD CODE; ESS1/PIN1; PEPTIDYL PROLYL CIS/TRANS ISOMERASE; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION REGULATION;

GENE EXPRESSION REGULATION, FUNGAL; PEPTIDYLPROLYL ISOMERASE; PROTEIN BINDING; RNA POLYMERASE II; RNA, MESSENGER; RNA, UNTRANSLATED; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION, GENETIC;

EID: 84896933783     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.02.001     Document Type: Review

References (232)

1. Lu K.P., Hanes S.D., Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996, 380:544-547.
2. Joseph J.D., Yeh E.S., Swenson K.I., Means A.R., Winkler K.E. The peptidyl-prolyl isomerase Pin1. Prog. Cell Cycle Res. 2003, 5:477-487.
3. Wulf G., Ryo A., Liou Y.C., Lu K.P. The prolyl isomerase Pin1 in breast development and cancer. Breast Cancer Res. 2003, 5:76-82.
4. Etzkorn F.A. Pin1 flips Alzheimer's switch. ACS Chem. Biol. 2006, 1:214-216.
5. Yeh E.S., Means A.R. PIN1, the cell cycle and cancer. Nat. Rev. Cancer 2007, 7:381-388.
6. Takahashi K., Uchida C., Shin R.W., Shimazaki K., Uchida T. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease. Cell. Mol. Life Sci. 2008, 65:359-375.
7. Lee T.H., Pastorino L., Lu K.P. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert. Rev. Mol. Med. 2011, 13:e21.
8. Liou Y.C., Zhou X.Z., Lu K.P. Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem. Sci. 2011, 36:501-514.
9. Esnault S., Shen Z.J., Malter J.S. Pinning down signaling in the immune system: the role of the peptidyl-prolyl isomerase Pin1 in immune cell function. Crit. Rev. Immunol. 2008, 28:45-60.
10. Shaw P.E. Peptidyl-prolyl isomerases: a new twist to transcription. EMBO J. Rep. 2002, 3:521-526.
11. Shaw P.E. Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?. EMBO J. Rep. 2007, 8:40-45.
12. Xu Y.X., Manley J.L. Pinning down transcription: regulation of RNA polymerase II activity during the cell cycle. Cell Cycle 2004, 3:432-435.
13. Ryo A., Suizu F., Yoshida Y., Perrem K., Liou Y.C., Wulf G., Rottapel R., Yamaoka S., Lu K.P. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 2003, 12:1413-1426.
14. Mantovani F., Piazza S., Gostissa M., Strano S., Zacchi P., Mantovani R., Blandino G., Del Sal G. Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol. Cell 2004, 14:625-636.
15. Zacchi P., Gostissa M., Uchida T., Salvagno C., Avolio F., Volinia S., Ronai Z., Blandino G., Schneider C., Del Sal G. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002, 419:853-857.
16. Ryo A., Nakamura M., Wulf G., Liou Y.C., Lu K.P. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 2001, 3:793-801.
17. Hanes S.D. Isolation, Sequence and Mutational Analysis of ESS1, a Gene Essential for Growth in Saccharomyces cerevisiase 1988, Ph.D. Thesis, Division of Biology and Medicine, Brown University, Providence, RI.
18. Hanes S.D., Shank P.R., Bostian K.A. Sequence and mutational analysis of ESS1, a gene essential for growth in Saccharomyces cerevisiae. Yeast 1989, 5:55-72.
19. Goebl M.G., Petes T.D. Most of the yeast genomic sequences are not essential for cell growth and division. Cell 1986, 46:983-992.
20. Shortle D., Haber J.E., Botstein D. Lethal disruption of the yeast actin gene by integrative DNA transformation. Science 1982, 217:371-373.
21. Rothstein R.J. One-step gene disruption in yeast. Methods Enzymol. 1983, 101:202-211.
22. Gemmill T.R., Wu X., Hanes S.D. Vanishingly low levels of Ess1 prolyl-isomerase activity are sufficient for growth in Saccharomyces cerevisiae. J. Biol. Chem. 2005, 280:15510-15517.
23. Wu X., Wilcox C.B., Devasahayam G., Hackett R.L., Arevalo-Rodriguez M., Cardenas M.E., Heitman J., Hanes S.D. The Ess1 prolyl isomerase is linked to chromatin remodeling complexes and the general transcription machinery. EMBO J. 2000, 19:3727-3738.
24. Fischer G., Bang H., Mech C. Determination of enzymatic catalysis for the cis-trans-isomerization of peptide binding in proline-containing peptides. Biomed. Biochim. Acta 1984, 43:1101-1111.
25. Schiene C., Fischer G. Enzymes that catalyse the restructuring of proteins. Curr. Opin. Struct. Biol. 2000, 10:40-45.
26. Fanghanel J., Fischer G. Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases. Front. Biosci. 2004, 9:3453-3478.
27. Schiene-Fischer C., Aumuller T., Fischer G. Peptide bond cis/trans isomerases: a biocatalysis perspective of conformational dynamics in proteins. Top. Curr. Chem. 2013, 328:35-67.
28. Schmid F.X. Prolyl isomerase: enzymatic catalysis of slow protein-folding reactions. Annu. Rev. Biophys. Biomol. Struct. 1993, 22:123-142.
29. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 1984, 226:544-547.
30. Harding M.W., Galat A., Uehling D.E., Schreiber S.L. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 1989, 341:758-760.
31. Siekierka J.J., Hung S.H., Poe M., Lin C.S., Sigal N.H. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 1989, 341:755-757.
32. Rahfeld J.U., Rucknagel K.P., Schelbert B., Ludwig B., Hacker J., Mann K., Fischer G. Confirmation of the existence of a third family among peptidyl-prolyl cis/trans isomerases. Amino acid sequence and recombinant production of parvulin. FEBS Lett. 1994, 352:180-184.
33. Hani J., Stumpf G., Domdey H. PTF1 encodes an essential protein in Saccharomyces cerevisiae, which shows strong homology with a new putative family of PPIases. FEBS Lett. 1995, 365:198-202.
34. Sudol M., Chen H.I., Bougeret C., Einbond A., Bork P. Characterization of a novel protein-binding module-the WW domain. FEBS Lett. 1995, 369:67-71.
35. Macias M.J., Wiesner S., Sudol M. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett. 2002, 513:30-37.
36. Bork P., Sudol M. The WW domain: a signalling site in dystrophin?. Trends Biochem. Sci. 1994, 19:531-533.
37. Maleszka R., Hanes S.D., Hackett R.L., de Couet H.G., Miklos G.L. The Drosophila melanogaster dodo (dod) gene, conserved in humans, is functionally interchangeable with the ESS1 cell division gene of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:447-451.
38. Crenshaw D.G., Yang J., Means A.R., Kornbluth S. The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. EMBO J. 1998, 17:1315-1327.
39. Shen M., Stukenberg P.T., Kirschner M.W., Lu K.P. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 1998, 12:706-720.
40. Fujimori F., Takahashi K., Uchida C., Uchida T. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem. Biophys. Res. Commun. 1999, 265:658-663.
41. Erben E.D., Daum S., Tellez-Inon M.T. The Trypanosoma cruzi PIN1 gene encodes a parvulin peptidyl-prolyl cis/trans isomerase able to replace the essential ESS1 in Saccharomyces cerevisiae. Mol. Biochem. Parasitol. 2007, 153:186-193.
42. Huang H.K., Forsburg S.L., John U.P., O'Connell M.J., Hunter T. Isolation and characterization of the Pin1/Ess1p homologue in Schizosaccharomyces pombe. J. Cell Sci. 2001, 114:3779-3788.
43. Devasahayam G., Chaturvedi V., Hanes S.D. The Ess1 prolyl isomerase is required for growth and morphogenetic switching in Candida albicans. Genetics 2002, 160:37-48.
44. Ren P., Rossettini A., Chaturvedi V., Hanes S.D. The Ess1 prolyl isomerase is dispensable for growth but required for virulence in Cryptococcus neoformans. Microbiology 2005, 151:1593-1605.
45. Behrsin C.D., Bailey M.L., Bateman K.S., Hamilton K.S., Wahl L.M., Brandl C.J., Shilton B.H., Litchfield D.W. Functionally important residues in the peptidyl-prolyl isomerase Pin1 revealed by unigenic evolution. J. Mol. Biol. 2007, 365:1143-1162.
46. Zhou X.Z., Kops O., Werner A., Lu P.J., Shen M., Stoller G., Kullertz G., Stark M., Fischer G., Lu K.P. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 2000, 6:873-883.
47. Uchida T., Fujimori F., Tradler T., Fischer G., Rahfeld J.U. Identification and characterization of a 14kDa human protein as a novel parvulin-like peptidyl prolyl cis/trans isomerase. FEBS Lett. 1999, 446:278-282.
48. Rulten S., Thorpe J., Kay J. Identification of eukaryotic parvulin homologues: a new subfamily of peptidylprolyl cis-trans isomerases. Biochem. Biophys. Res. Commun. 1999, 259:557-562.
49. Surmacz T.A., Bayer E., Rahfeld J.U., Fischer G., Bayer P. The N-terminal basic domain of human parvulin hPar14 is responsible for the entry to the nucleus and high-affinity DNA-binding. J. Mol. Biol. 2002, 321:235-247.
50. Fujiyama S., Yanagida M., Hayano T., Miura Y., Isobe T., Fujimori F., Uchida T., Takahashi N. Isolation and proteomic characterization of human Parvulin-associating preribosomal ribonucleoprotein complexes. J. Biol. Chem. 2002, 277:23773-23780.
51. Fujiyama-Nakamura S., Yoshikawa H., Homma K., Hayano T., Tsujimura-Takahashi T., Izumikawa K., Ishikawa H., Miyazawa N., Yanagida M., Miura Y., Shinkawa T., Yamauchi Y., Isobe T., Takahashi N. Parvulin (Par14), a peptidyl-prolyl cis-trans isomerase, is a novel rRNA processing factor that evolved in the metazoan lineage. Mol. Cell. Proteomics 2009, 8:1552-1565.
52. Metzner M., Stoller G., Rucknagel K.P., Lu K.P., Fischer G., Luckner M., Kullertz G. Functional replacement of the essential ESS1 in yeast by the plant parvulin DlPar13. J. Biol. Chem. 2001, 276:13524-13529.
53. Kessler D., Papatheodorou P., Stratmann T., Dian E.A., Hartmann-Fatu C., Rassow J., Bayer P., Mueller J.W. The DNA binding parvulin Par17 is targeted to the mitochondrial matrix by a recently evolved prepeptide uniquely present in Hominidae. BMC Biol. 2007, 5:37.
54. Mueller J.W., Bayer P. Small family with key contacts: par14 and par17 parvulin proteins, relatives of Pin1, now emerge in biomedical research. Perspect. Med. Chem. 2008, 2:11-20.
55. Campbell H.D., Webb G.C., Fountain S., Young I.G. The human PIN1 peptidyl-prolyl cis/trans isomerase gene maps to human chromosome 19p13 and the closely related PIN1L gene to 1p31. Genomics 1997, 44:157-162.
56. -/- mice. FEBS Lett. 2006, 580:3237-3245.
57. Akiyama H., Gotoh A., Shin R.W., Koga T., Ohashi T., Sakamoto W., Harada A., Arai H., Sawa A., Uchida C., Uchida T. A novel role for hGas7b in microtubular maintenance: possible implication in tau-associated pathology in Alzheimer disease. J. Biol. Chem. 2009, 284:32695-32699.
58. Landrieu I., De Veylder L., Fruchart J.S., Odaert B., Casteels P., Portetelle D., Van Montagu M., Inze D., Lippens G. The Arabidopsis thaliana PIN1At gene encodes a single-domain phosphorylation-dependent peptidyl prolyl cis/trans isomerase. J. Biol. Chem. 2000, 275:10577-10581.
59. He Z., Li L., Luan S. Immunophilins and parvulins. Superfamily of peptidyl prolyl isomerases in Arabidopsis. Plant Physiol. 2004, 134:1248-1267.
60. Yao J.L., Kops O., Lu P.J., Lu K.P. Functional conservation of phosphorylation-specific prolyl isomerases in plants. J. Biol. Chem. 2001, 276:13517-13523.
61. Dharmasiri N., Dharmasiri S., Jones A.M., Estelle M. Auxin action in a cell-free system. Curr. Biol. 2003, 13:1418-1422.
62. Wang Y., Liu C., Yang D., Yu H., Liou Y.C. Pin1At encoding a peptidyl-prolyl cis/trans isomerase regulates flowering time in Arabidopsis. Mol. Cell 2010, 37:112-122.
63. Jaremko L., Jaremko M., Elfaki I., Mueller J.W., Ejchart A., Bayer P., Zhukov I. Structure and dynamics of the first archaeal parvulin reveal a new functionally important loop in parvulin-type prolyl isomerases. J. Biol. Chem. 2011, 286:6554-6565.
64. Arevalo-Rodriguez M., Wu X., Hanes S.D., Heitman J. Prolyl isomerases in yeast. Front. Biosci. 2004, 9:2420-2446.
65. Ranganathan R., Lu K.P., Hunter T., Noel J.P. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 1997, 89:875-886.
66. Ng C.A., Kato Y., Tanokura M., Brownlee R.T. Structural characterisation of PinA WW domain and a comparison with other group IV WW domains, Pin1 and Ess1. Biochim. Biophys. Acta 2008, 1784:1208-1214.
67. Sudol M., Hunter T. NeW wrinkles for an old domain. Cell 2000, 103:1001-1004.
68. Lu P.J., Zhou X.Z., Shen M., Lu K.P. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 1999, 283:1325-1328.
69. Verdecia M.A., Bowman M.E., Lu K.P., Hunter T., Noel J.P. Structural basis for phosphoserine-proline recognition by group IV WW domains. Nat. Struct. Biol. 2000, 7:639-643.
70. Bayer E., Goettsch S., Mueller J.W., Griewel B., Guiberman E., Mayr L.M., Bayer P. Structural analysis of the mitotic regulator hPin1 in solution: insights into domain architecture and substrate binding. J. Biol. Chem. 2003, 278:26183-26193.
71. Jacobs D.M., Saxena K., Vogtherr M., Bernado P., Pons M., Fiebig K.M. Peptide binding induces large scale changes in inter-domain mobility in human Pin1. J. Biol. Chem. 2003, 278:26174-26182.
72. Matena A., Sinnen C., van den Boom J., Wilms C., Dybowski J.N., Maltaner R., Mueller J.W., Link N.M., Hoffmann D., Bayer P. Transient domain interactions enhance the affinity of the mitotic regulator Pin1 toward phosphorylated peptide ligands. Structure 2013, 21:1769-1777.
73. Labeikovsky W., Eisenmesser E.Z., Bosco D.A., Kern D. Structure and dynamics of Pin1 during catalysis by NMR. J. Mol. Biol. 2007, 367:1370-1381.
74. Daum S., Lucke C., Wildemann D., Schiene-Fischer C. On the benefit of bivalency in peptide ligand/pin1 interactions. J. Mol. Biol. 2007, 374:147-161.
75. Li Z., Li H., Devasahayam G., Gemmill T., Chaturvedi V., Hanes S.D., Van Roey P. The structure of the Candida albicans Ess1 prolyl isomerase reveals a well-ordered linker that restricts domain mobility. Biochemistry 2005, 44:6180-6189.
76. McNaughton L., Li Z., Van Roey P., Hanes S.D., LeMaster D.M. Restricted domain mobility in the Candida albicans Ess1 prolyl isomerase. Biochim. Biophys. Acta 2010, 1804:1537-1541.
77. Lippens G., Landrieu I., Smet C. Molecular mechanisms of the phospho-dependent prolyl cis/trans isomerase Pin1. FEBS J. 2007, 274:5211-5222.
78. Park S.T., Aldape R.A., Futer O., DeCenzo M.T., Livingston D.J. PPIase catalysis by human FK506-binding protein proceeds through a conformational twist mechanism. J. Biol. Chem. 1992, 267:3316-3324.
79. Kofron J.L., Kuzmic P., Kishore V., Colon-Bonilla E., Rich D.H. Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay. Biochemistry 1991, 30:6127-6134.
80. Grathwohl C., Wuthrich K. Nmr studies of the molecular conformations in the linear oligopeptides H-(L-Ala)n-L-Pro-OH. Biopolymers 1976, 15:2043-2057.
81. Cheng H.N., Bovey F.A. Cis-trans equilibrium and kinetic studies of acetyl-l-proline and glycyl-l-proline. Biopolymers 1977, 16:1465-1472.
82. Stimson E.R., Montelione G.T., Meinwald Y.C., Rudolph R.K., Scheraga H.A. Equilibrium ratios of cis- and trans-proline conformers in fragments of ribonuclease A from nuclear magnetic resonance spectra of adjacent tyrosine ring resonances. Biochemistry 1982, 21:5252-5262.
83. Schmid F.X., Baldwin R.L. Acid catalysis of the formation of the slow-folding species of RNase A: evidence that the reaction is proline isomerization. Proc. Natl. Acad. Sci. U. S. A. 1978, 75:4764-4768.
84. Wildemann D., Erdmann F., Alvarez B.H., Stoller G., Zhou X.Z., Fanghanel J., Schutkowski M., Lu K.P., Fischer G. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries. J. Med. Chem. 2006, 49:2147-2150.
85. Wu X., Chang A., Sudol M., Hanes S.D. Genetic interactions between the ESS1 prolyl-isomerase and the RSP5 ubiquitin ligase reveal opposing effects on RNA polymerase II function. Curr. Genet. 2001, 40:234-242.
86. Innes B.T., Bailey M.L., Brandl C.J., Shilton B.H., Litchfield D.W. Non-catalytic participation of the Pin1 peptidyl-prolyl isomerase domain in target binding. Front. Physiol. 2013, 4:18.
87. Myers J.K., Morris D.P., Greenleaf A.L., Oas T.G. Phosphorylation of RNA polymerase II CTD fragments results in tight binding to the WW domain from the yeast prolyl isomerase Ess1. Biochemistry 2001, 40:8479-8486.
88. Kern D., Drakenberg T., Wikstrom M., Forsen S., Bang H., Fischer G. The cis/trans interconversion of the calcium regulating hormone calcitonin is catalyzed by cyclophilin. FEBS Lett. 1993, 323:198-202.
89. Atencio D., Barnes C., Duncan T.M., Willis I.M., Hanes S.D. The yeast Ess1 prolyl isomerase controls Swi6 and Whi5 nuclear localization. Genes, Genome., Gen. 2014, (Epub ahead of print) (January 27). 10.1534/g3.113.008763.
90. Zhang Y., Fussel S., Reimer U., Schutkowski M., Fischer G. Substrate-based design of reversible Pin1 inhibitors. Biochemistry 2002, 41:11868-11877.
91. Landrieu I., Smet C., Wieruszeski J.M., Sambo A.V., Wintjens R., Buee L., Lippens G. Exploring the molecular function of PIN1 by nuclear magnetic resonance. Curr. Protein Pept. Sci. 2006, 7:179-194.
92. Schutkowski M., Bernhardt A., Zhou X.Z., Shen M., Reimer U., Rahfeld J.U., Lu K.P., Fischer G. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition. Biochemistry 1998, 37:5566-5575.
93. Wedemeyer W.J., Welker E., Scheraga H.A. Proline cis-trans isomerization and protein folding. Biochemistry 2002, 41:14637-14644.
94. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J.U., Xu J., Kuang J., Kirschner M.W., Fischer G., Cantley L.C., Lu K.P. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278:1957-1960.
95. Wilcox C.B., Rossettini A., Hanes S.D. Genetic interactions with C-terminal domain (CTD) kinases and the CTD of RNA Pol II suggest a role for ESS1 in transcription initiation and elongation in Saccharomyces cerevisiae. Genetics 2004, 167:93-105.
96. Mann R.S. The specificity of homeotic gene function. Bioessays 1995, 17:855-863.
97. Biggin M.D., McGinnis W. Regulation of segmentation and segmental identity by Drosophila homeoproteins: the role of DNA binding in functional activity and specificity. Development 1997, 124:4425-4433.
98. Hall F.L., Vulliet P.R. Proline-directed protein phosphorylation and cell cycle regulation. Curr. Opin. Cell Biol. 1991, 3:176-184.
99. Lim S., Kaldis P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development 2013, 140:3079-3093.
100. Pelech S.L. Networking with proline-directed protein kinases implicated in tau phosphorylation. Neurobiol. Aging 1995, 16:247-256. (discussion 257-261).
101. Mercedes-Camacho A.Y., Mullins A.B., Mason M.D., Xu G.G., Mahoney B.J., Wang X., Peng J.W., Etzkorn F.A. Kinetic isotope effects support the twisted amide mechanism of Pin1 peptidyl-prolyl isomerase. Biochemistry 2013, 52:7707-7713.
102. Zhang Y., Daum S., Wildemann D., Zhou X.Z., Verdecia M.A., Bowman M.E., Lucke C., Hunter T., Lu K.P., Fischer G., Noel J.P. Structural basis for high-affinity peptide inhibition of human Pin1. ACS Chem. Biol. 2007, 2:320-328.
103. Vohringer-Martinez E., Duarte F., Toro-Labbe A. How does Pin1 catalyze the cis-trans prolyl peptide bond isomerization? A QM/MM and mean reaction force study. J. Phys. Chem. B 2012, 116:12972-12979.
104. Bailey M.L., Shilton B.H., Brandl C.J., Litchfield D.W. The dual histidine motif in the active site of Pin1 has a structural rather than catalytic role. Biochemistry 2008, 47:11481-11489.
105. Harrison R.K., Stein R.L. Mechanistic studies of peptidyl prolyl cis-trans isomerase: evidence for catalysis by distortion. Biochemistry 1990, 29:1684-1689.
106. Fischer S., Michnick S., Karplus M. A mechanism for rotamase catalysis by the FK506 binding protein. Biochemistry 1993, 32:13830-13837.
107. Hennig L., Christner C., Kipping M., Schelbert B., Rucknagel K.P., Grabley S., Kullertz G., Fischer G. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 1998, 37:5953-5960.
108. Duncan K.E., Dempsey B.R., Killip L.E., Adams J., Bailey M.L., Lajoie G.A., Litchfield D.W., Brandl C.J., Shaw G.S., Shilton B.H. Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1. J. Med. Chem. 2011, 54:3854-3865.
109. Liu T., Liu Y., Kao H.Y., Pei D. Membrane permeable cyclic peptidyl inhibitors against human peptidylprolyl isomerase Pin1. J. Med. Chem. 2010, 53:2494-2501.
110. Wang X.J., Xu B., Mullins A.B., Neiler F.K., Etzkorn F.A. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere. J. Am. Chem. Soc. 2004, 126:15533-15542.
111. Zhao S., Etzkorn F.A. A phosphorylated prodrug for the inhibition of Pin1. Bioorg. Med. Chem. Lett. 2007, 17:6615-6618.
112. Smet C., Wieruszeski J.M., Buee L., Landrieu I., Lippens G. Regulation of Pin1 peptidyl-prolyl cis/trans isomerase activity by its WW binding module on a multi-phosphorylated peptide of Tau protein. FEBS Lett. 2005, 579:4159-4164.
113. Namanja A.T., Wang X.J., Xu B., Mercedes-Camacho A.Y., Wilson K.A., Etzkorn F.A., Peng J.W. Stereospecific gating of functional motions in Pin1. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:12289-12294.
114. Hani J., Schelbert B., Bernhardt A., Domdey H., Fischer G., Wiebauer K., Rahfeld J.U. Mutations in a peptidylprolyl-cis/trans-isomerase gene lead to a defect in 3'-end formation of a pre-mRNA in Saccharomyces cerevisiae. J. Biol. Chem. 1999, 274:108-116.
115. Albert A., Lavoie S., Vincent M. A hyperphosphorylated form of RNA polymerase II is the major interphase antigen of the phosphoprotein antibody MPM-2 and interacts with the peptidyl-prolyl isomerase Pin1. J. Cell Sci. 1999, 112(Pt 15):2493-2500.
116. Morris D.P., Phatnani H.P., Greenleaf A.L. Phospho-carboxyl-terminal domain binding and the role of a prolyl isomerase in pre-mRNA 3'-end formation. J. Biol. Chem. 1999, 274:31583-31587.
117. Kinkelin K., Wozniak G.G., Rothbart S.B., Lidschreiber M., Strahl B.D., Cramer P. Structures of RNA polymerase II complexes with Bye1, a chromatin-binding PHF3/DIDO homologue. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:15277-15282.
118. Wu X., Rossettini A., Hanes S.D. The ESS1 prolyl isomerase and its suppressor BYE1 interact with RNA pol II to inhibit transcription elongation in Saccharomyces cerevisiae. Genetics 2003, 165:1687-1702.
119. Kobor M.S., Archambault J., Lester W., Holstege F.C., Gileadi O., Jansma D.B., Jennings E.G., Kouyoumdjian F., Davidson A.R., Young R.A., Greenblatt J. An unusual eukaryotic protein phosphatase required for transcription by RNA polymerase II and CTD dephosphorylation in S. cerevisiae. Mol. Cell 1999, 4:55-62.
120. Zhang Y., Sun Z.W., Iratni R., Erdjument-Bromage H., Tempst P., Hampsey M., Reinberg D. SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex. Mol. Cell 1998, 1:1021-1031.
121. Parkhurst S.M., Ish-Horowicz D. Wimp, a dominant maternal-effect mutation, reduces transcription of a specific subset of segmentation genes in Drosophila. Genes Dev. 1991, 5:341-357.
122. Krishnamurthy S., Ghazy M.A., Moore C., Hampsey M. Functional interaction of the Ess1 prolyl isomerase with components of the RNA polymerase II initiation and termination machineries. Mol. Cell. Biol. 2009, 29:2925-2934.
123. Kops O., Zhou X.Z., Lu K.P. Pin1 modulates the dephosphorylation of the RNA polymerase II C-terminal domain by yeast Fcp1. FEBS Lett. 2002, 513:305-311.
124. Buratowski S. The CTD code. Nat. Struct. Biol. 2003, 10:679-680.
125. Xu Y.X., Hirose Y., Zhou X.Z., Lu K.P., Manley J.L. Pin1 modulates the structure and function of human RNA polymerase II. Genes Dev. 2003, 17:2765-2776.
126. Palancade B., Marshall N.F., Tremeau-Bravard A., Bensaude O., Dahmus M.E., Dubois M.F. Dephosphorylation of RNA polymerase II by CTD-phosphatase FCP1 is inhibited by phospho-CTD associating proteins. J. Mol. Biol. 2004, 335:415-424.
127. Xu Y.X., Manley J.L. Pin1 modulates RNA polymerase II activity during the transcription cycle. Genes Dev. 2007, 21:2950-2962.
128. Ma Z., Atencio D., Barnes C., DeFiglio H., Hanes S.D. Multiple roles for the Ess1 prolyl isomerase in the RNA polymerase II transcription cycle. Mol. Cell. Biol. 2012, 32:3594-3607.
129. Singh N., Ma Z., Gemmill T., Wu X., Rossettini A., Rabeler C., Beane O., DeFiglio H., Palumbo M., Morse R., Hanes S.D. The Ess1 prolyl isomerase is required for transcription termination of small non-coding regulatory RNAs via the Nrd1 pathway. Mol. Cell 2009, 36:255-266.
130. Nazarenus T., Cedarberg R., Bell R., Cheatle J., Forch A., Haifley A., Hou A., Wanja Kebaara B., Shields C., Stoysich K., Taylor R., Atkin A.L. Upf1p, a highly conserved protein required for nonsense-mediated mRNA decay, interacts with the nuclear pore proteins Nup100p and Nup116p. Gene 2005, 345:199-212.
131. Amrani N., Dong S., He F., Ganesan R., Ghosh S., Kervestin S., Li C., Mangus D.A., Spatrick P., Jacobson A. Aberrant termination triggers nonsense-mediated mRNA decay. Biochem. Soc. Trans. 2006, 34:39-42.
132. Muhlemann O., Eberle A.B., Stalder L., Zamudio Orozco R. Recognition and elimination of nonsense mRNA. Biochim. Biophys. Acta 2008, 1779:538-549.
133. Porrua O., Libri D. RNA quality control in the nucleus: the Angels' share of RNA. Biochim. Biophys. Acta 2013, 1829:604-611.
134. Parker R. RNA degradation in Saccharomyces cerevisae. Genetics 2012, 191:671-702.
135. Chao S.H., Greenleaf A.L., Price D.H. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription. Nucleic Acids Res. 2001, 29:767-773.
136. Ganem C., Devaux F., Torchet C., Jacq C., Quevillon-Cheruel S., Labesse G., Facca C., Faye G. Ssu72 is a phosphatase essential for transcription termination of snoRNAs and specific mRNAs in yeast. EMBO J. 2003, 22:1588-1598.
137. Reichow S.L., Hamma T., Ferre-D'Amare A.R., Varani G. The structure and function of small nucleolar ribonucleoproteins. Nucleic Acids Res. 2007, 35:1452-1464.
138. Wyers F., Rougemaille M., Badis G., Rousselle J.C., Dufour M.E., Boulay J., Regnault B., Devaux F., Namane A., Seraphin B., Libri D., Jacquier A. Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase. Cell 2005, 121:725-737.
139. Arigo J.T., Eyler D.E., Carroll K.L., Corden J.L. Termination of cryptic unstable transcripts is directed by yeast RNA-binding proteins Nrd1 and Nab3. Mol. Cell 2006, 23:841-851.
140. Thiebaut M., Kisseleva-Romanova E., Rougemaille M., Boulay J., Libri D. Transcription termination and nuclear degradation of cryptic unstable transcripts: a role for the Nrd1-Nab3 pathway in genome surveillance. Mol. Cell 2006, 23:853-864.
141. Dichtl B. Transcriptional shortCUTs. Mol. Cell 2008, 31:617-618.
142. Rougemaille M., Libri D. Control of cryptic transcription in eukaryotes. Adv. Exp. Med. Biol. 2011, 702:122-131.
143. Colin J., Libri D., Porrua O. Cryptic transcription and early termination in the control of gene expression. Genet. Res. Int. 2011, 2011:653494.
144. Rougemaille M., Libri D. Control of cryptic transcription in eukaryotes. Adv. Exp. Med. Biol. 2010, 702:122-131.
145. Samaranayake D., Atencio D., Morse R., Wade J.T., Chaturvedi V., Hanes S.D. Role of Ess1 in growth, morphogenetic switching, and RNA polymerase II transcription in Candida albicans. PLoS One 2013, 8:e59094.
146. Siepe D., Jentsch S. Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation. Nat. Cell Biol. 2009, 11:967-972.
147. Hong S.W., Hong S.M., Yoo J.W., Lee Y.C., Kim S., Lis J.T., Lee D.K. Phosphorylation of the RNA polymerase II C-terminal domain by TFIIH kinase is not essential for transcription of Saccharomyces cerevisiae genome. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14276-14280.
148. Hengartner C.J., Myer V.E., Liao S.M., Wilson C.J., Koh S.S., Young R.A. Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol. Cell 1998, 2:43-53.
149. Liu Y., Kung C., Fishburn J., Ansari A.Z., Shokat K.M., Hahn S. Two cyclin-dependent kinases promote RNA polymerase II transcription and formation of the scaffold complex. Mol. Cell. Biol. 2004, 24:1721-1735.
150. Aristizabal M.J., Negri G.L., Benschop J.J., Holstege F.C., Krogan N.J., Kobor M.S. High-throughput genetic and gene expression analysis of the RNAPII-CTD reveals unexpected connections to SRB10/CDK8. PLoS Genet. 2013, 9:e1003758.
151. Riles L., Shaw R.J., Johnston M., Reines D. Large-scale screening of yeast mutants for sensitivity to the IMP dehydrogenase inhibitor 6-azauracil. Yeast 2004, 21:241-248.
152. Eick D., Geyer M. The RNA polymerase II carboxy-terminal domain (CTD) code. Chem. Rev. 2013, 113:8456-8490.
153. Heidemann M., Hintermair C., Voss K., Eick D. Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription. Biochim. Biophys. Acta 2013, 1829:55-62.
154. Buratowski S. Progression through the RNA polymerase II CTD cycle. Mol. Cell 2009, 36:541-546.
155. Perales R., Bentley D. "Cotranscriptionality": the transcription elongation complex as a nexus for nuclear transactions. Mol. Cell 2009, 36:178-191.
156. Egloff S., Murphy S. Cracking the RNA polymerase II CTD code. Trends Genet. 2008, 24:280-288.
157. Egloff S., Dienstbier M., Murphy S. Updating the RNA polymerase CTD code: adding gene-specific layers. Trends Genet. 2012, 28:333-341.
158. Hsin J.P., Manley J.L. The RNA polymerase II CTD coordinates transcription and RNA processing. Genes Dev. 2012, 26:2119-2137.
159. Drogat J., Hermand D. Gene-specific requirement of RNA polymerase II CTD phosphorylation. Mol. Microbiol. 2012, 84:995-1004.
160. Bartkowiak B., Mackellar A.L., Greenleaf A.L. Updating the CTD story: from tail to epic. Genet. Res. Int. 2011, 2011:623718.
161. Schwer B., Shuman S. Deciphering the RNA polymerase II CTD code in fission yeast. Mol. Cell 2011, 43:311-318.
162. Zhang D.W., Rodriguez-Molina J.B., Tietjen J.R., Nemec C.M., Ansari A.Z. Emerging views on the CTD code. Genet. Res. Int. 2012, 2012:347214.
163. Jeronimo C., Bataille A.R., Robert F. The writers, readers, and functions of the RNA polymerase II C-terminal domain code. Chem. Rev. 2013, 113:8491-8522.
164. Corden J.L. RNA polymerase II C-terminal domain: tethering transcription to transcript and template. Chem. Rev. 2013, 113:8423-8455.
165. West M.L., Corden J.L. Construction and analysis of yeast RNA polymerase II CTD deletion and substitution mutations. Genetics 1995, 140:1223-1233.
166. Nonet M.L., Young R.A. Intragenic and extragenic suppressors of mutations in the heptapeptide repeat domain of Saccharomyces cerevisiae RNA polymerase II. Genetics 1989, 123:715-724.
167. Fong N., Bentley D.L. Capping, splicing, and 3' processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD. Genes Dev. 2001, 15:1783-1795.
168. Stiller J.W., Cook M.S. Functional unit of the RNA polymerase II C-terminal domain lies within heptapeptide pairs. Eukaryot. Cell 2004, 3:735-740.
169. Fabrega C., Shen V., Shuman S., Lima C.D. Structure of an mRNA capping enzyme bound to the phosphorylated carboxy-terminal domain of RNA polymerase II. Mol. Cell 2003, 11:1549-1561.
170. Heidemann M., Hintermair C., Voss K., Eick D. Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription. BBA-Gene Regulatory Mechanisms 2013, 1829:55-62.
171. Kelly W.G., Dahmus M.E., Hart G.W. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J. Biol. Chem. 1993, 268:10416-10424.
172. Ranuncolo S.M., Ghosh S., Hanover J.A., Hart G.W., Lewis B.A. Evidence of the involvement of O-GlcNAc-modified human RNA polymerase II CTD in transcription in vitro and in vivo. J. Biol. Chem. 2012, 287:23549-23561.
173. Sims R.J., Rojas L.A., Beck D., Bonasio R., Schuller R., Drury W.J., Eick D., Reinberg D. The C-terminal domain of RNA polymerase II is modified by site-specific methylation. Science 2011, 332:99-103.
174. Stiller J.W., McConaughy B.L., Hall B.D. Evolutionary complementation for polymerase II CTD function. Yeast 2000, 16:57-64.
175. Karagiannis J. Decoding the informational properties of the RNA polymerase II carboxy terminal domain. BMC Res. Notes 2012, 5:241.
176. Komarnitsky P., Cho E.J., Buratowski S. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 2000, 14:2452-2460.
177. Schroeder S.C., Schwer B., Shuman S., Bentley D. Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev. 2000, 14:2435-2440.
178. O'Brien T., Hardin S., Greenleaf A., Lis J.T. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature 1994, 370:75-77.
179. Lee J.M., Greenleaf A.L. A protein kinase that phosphorylates the C-terminal repeat domain of the largest subunit of RNA polymerase II. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:3624-3628.
180. Lin P.S., Marshall N.F., Dahmus M.E. CTD phosphatase: role in RNA polymerase II cycling and the regulation of transcript elongation. Prog. Nucleic Acid Res. Mol. Biol. 2002, 72:333-365.
181. Kim H., Erickson B., Luo W., Seward D., Graber J.H., Pollock D.D., Megee P.C., Bentley D.L. Gene-specific RNA polymerase II phosphorylation and the CTD code. Nat. Struct. Mol. Biol. 2010, 17:1279-1286.
182. Tietjen J.R., Zhang D.W., Rodriguez-Molina J.B., White B.E., Akhtar M.S., Heidemann M., Li X., Chapman R.D., Shokat K., Keles S., Eick D., Ansari A.Z. Chemical-genomic dissection of the CTD code. Nat. Struct. Mol. Biol. 2010, 17:1154-1161.
183. Mayer A., Lidschreiber M., Siebert M., Leike K., Soding J., Cramer P. Uniform transitions of the general RNA polymerase II transcription complex. Nat. Struct. Mol. Biol. 2010, 17:1272-1278.
184. Bataille A.R., Jeronimo C., Jacques P.-E., Laramée L., Fortin M.-E., Forest A., Bergeron M., Hanes S.D., Robert F. A universal RNA polymerase II CTD cycle is orchestrated by complex interplays between kinase, phosphatase and isomerase enzymes along genes. Mol. Cell 2012, 45:158-170.
185. Hirose Y., Ohkuma Y. Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression. J. Biochem. 2007, 141:601-608.
186. Majello B., Napolitano G. Control of RNA polymerase II activity by dedicated CTD kinases and phosphatases. Front. Biosci. 2001, 6:D1358-D1368.
187. Kang M.E., Dahmus M.E. RNA polymerases IIA and IIO have distinct roles during transcription from the TATA-less murine dihydrofolate reductase promoter. J. Biol. Chem. 1993, 268:25033-25040.
188. Zehring W.A., Lee J.M., Weeks J.R., Jokerst R.S., Greenleaf A.L. The C-terminal repeat domain of RNA polymerase II largest subunit is essential in vivo but is not required for accurate transcription initiation in vitro. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:3698-3702.
189. Buratowski S., Sharp P.A. Transcription initiation complexes and upstream activation with RNA polymerase II lacking the C-terminal domain of the largest subunit. Mol. Cell. Biol. 1990, 10:5562-5564.
190. Kim W.Y., Dahmus M.E. The major late promoter of adenovirus-2 is accurately transcribed by RNA polymerases IIO, IIA, and IIB. J. Biol. Chem. 1989, 264:3169-3176.
191. Chapman R.D., Heidemann M., Albert T.K., Mailhammer R., Flatley A., Meisterernst M., Kremmer E., Eick D. Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7. Science 2007, 318:1780-1782.
192. Steinmetz E.J., Conrad N.K., Brow D.A., Corden J.L. RNA-binding protein Nrd1 directs poly(A)-independent 3'-end formation of RNA polymerase II transcripts. Nature 2001, 413:327-331.
193. Carroll K.L., Ghirlando R., Ames J.M., Corden J.L. Interaction of yeast RNA-binding proteins Nrd1 and Nab3 with RNA polymerase II terminator elements. RNA 2007, 13:361-373.
194. Vasiljeva L., Buratowski S. Nrd1 interacts with the nuclear exosome for 3' processing of RNA polymerase II transcripts. Mol. Cell 2006, 21:239-248.
195. Steinmetz E.J., Warren C.L., Kuehner J.N., Panbehi B., Ansari A.Z., Brow D.A. Genome-wide distribution of yeast RNA polymerase II and its control by Sen1 helicase. Mol. Cell 2006, 24:735-746.
196. Amrani N., Minet M., Wyers F., Dufour M.E., Aggerbeck L.P., Lacroute F. PCF11 encodes a third protein component of yeast cleavage and polyadenylation factor I. Mol. Cell. Biol. 1997, 17:1102-1109.
197. Zhang Z., Fu J., Gilmour D.S. CTD-dependent dismantling of the RNA polymerase II elongation complex by the pre-mRNA 3'-end processing factor, Pcf11. Genes Dev. 2005, 19:1572-1580.
198. Kim M., Vasiljeva L., Rando O.J., Zhelkovsky A., Moore C., Buratowski S. Distinct pathways for snoRNA and mRNA termination. Mol. Cell 2006, 24:723-734.
199. Licatalosi D.D., Geiger G., Minet M., Schroeder S., Cilli K., McNeil J.B., Bentley D.L. Functional interaction of yeast pre-mRNA 3' end processing factors with RNA polymerase II. Mol. Cell 2002, 9:1101-1111.
200. Krishnamurthy S., He X., Reyes-Reyes M., Moore C., Hampsey M. Ssu72 Is an RNA polymerase II CTD phosphatase. Mol. Cell 2004, 14:387-394.
201. Zhang D.W., Mosley A.L., Ramisetty S.R., Rodriguez-Molina J.B., Washburn M.P., Ansari A.Z. Ssu72 phosphatase-dependent erasure of phospho-Ser7 marks on the RNA polymerase II C-terminal domain is essential for viability and transcription termination. J. Biol. Chem. 2012, 287:8541-8551.
202. Jasnovidova O., Stefl R. The CTD code of RNA polymerase II: a structural view. Wiley Interdiscip. Rev. RNA 2013, 4:1-16.
203. Meinhart A., Kamenski T., Hoeppner S., Baumli S., Cramer P. A structural perspective of CTD function. Genes Dev. 2005, 19:1401-1415.
204. Ghosh A., Shuman S., Lima C.D. Structural insights to how mammalian capping enzyme reads the CTD code. Mol. Cell 2011, 43:299-310.
205. Werner-Allen J.W., Lee C.J., Liu P., Nicely N.I., Wang S., Greenleaf A.L., Zhou P. cis-Proline-mediated Ser(P)5 dephosphorylation by the RNA polymerase II C-terminal domain phosphatase Ssu72. J. Biol. Chem. 2011, 286:5717-5726.
206. Xiang K., Nagaike T., Xiang S., Kilic T., Beh M.M., Manley J.L., Tong L. Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex. Nature 2010, 467:729-733.
207. Zhang Y., Kim Y., Genoud N., Gao J., Kelly J.W., Pfaff S.L., Gill G.N., Dixon J.E., Noel J.P. Determinants for dephosphorylation of the RNA polymerase II C-terminal domain by Scp1. Mol. Cell 2006, 24:759-770.
208. Xiang K., Manley J.L., Tong L. An unexpected binding mode for a Pol II CTD peptide phosphorylated at Ser7 in the active site of the CTD phosphatase Ssu72. Genes Dev. 2012, 26:2265-2270.
209. Luo Y., Yogesha S.D., Cannon J.R., Yan W., Ellington A.D., Brodbelt J.S., Zhang Y. Novel modifications on C-terminal domain of RNA polymerase II can fine-tune the phosphatase activity of Ssu72. ACS Chem. Biol. 2013, 8:2042-2052.
210. Meinhart A., Cramer P. Recognition of RNA polymerase II carboxy-terminal domain by 3'-RNA-processing factors. Nature 2004, 430:223-226.
211. Noble C.G., Hollingworth D., Martin S.R., Ennis-Adeniran V., Smerdon S.J., Kelly G., Taylor I.A., Ramos A. Key features of the interaction between Pcf11 CID and RNA polymerase II CTD. Nat. Struct. Mol. Biol. 2005, 12:144-151.
212. Lunde B.M., Reichow S.L., Kim M., Suh H., Leeper T.C., Yang F., Mutschler H., Buratowski S., Meinhart A., Varani G. Cooperative interaction of transcription termination factors with the RNA polymerase II C-terminal domain. Nat. Struct. Mol. Biol. 2010, 17:1195-1201.
213. Kubicek K., Cerna H., Holub P., Pasulka J., Hrossova D., Loehr F., Hofr C., Vanacova S., Stefl R. Serine phosphorylation and proline isomerization in RNAP II CTD control recruitment of Nrd1. Genes Dev. 2012, 26:1891-1896.
214. Domingues M.N., de Campos B.M., de Oliveira M.L., de Mello U.Q., Benedetti C.E. TAL effectors target the C-terminal domain of RNA polymerase II (CTD) by inhibiting the prolyl-isomerase activity of a CTD-associated cyclophilin. PLoS One 2012, 7:e41553.
215. Govind C.K., Qiu H., Ginsburg D.S., Ruan C., Hofmeyer K., Hu C., Swaminathan V., Workman J.L., Li B., Hinnebusch A.G. Phosphorylated Pol II CTD recruits multiple HDACs, including Rpd3C(S), for methylation-dependent deacetylation of ORF nucleosomes. Mol. Cell 2010, 39:234-246.
216. Ng H.H., Robert F., Young R.A., Struhl K. Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. Mol. Cell 2003, 11:709-719.
217. Smolle M., Workman J.L. Transcription-associated histone modifications and cryptic transcription. BBA-Gene Regulatory Mechanisms 2013, 1829:84-97.
218. Arevalo-Rodriguez M., Cardenas M.E., Wu X., Hanes S.D., Heitman J. Cyclophilin A and Ess1 interact with and regulate silencing by the Sin3-Rpd3 histone deacetylase. EMBO J. 2000, 19:3739-3749.
219. Wang S.S., Zhou B.O., Zhou J.Q. Histone H3 lysine 4 hypermethylation prevents aberrant nucleosome remodeling at the PHO5 promoter. Mol. Cell. Biol. 2011, 31:3171-3181.
220. Li J., Moazed D., Gygi S.P. Association of the histone methyltransferase Set2 with RNA polymerase II plays a role in transcription elongation. J. Biol. Chem. 2002, 277:49383-49388.
221. Phatnani H.P., Jones J.C., Greenleaf A.L. Expanding the functional repertoire of CTD kinase I and RNA polymerase II: novel phosphoCTD-associating proteins in the yeast proteome. Biochemistry 2004, 43:15702-15719.
222. Geymonat M., Spanos A., Wells G.P., Smerdon S.J., Sedgwick S.G. Clb6/Cdc28 and Cdc14 regulate phosphorylation status and cellular localization of Swi6. Mol. Cell. Biol. 2004, 24:2277-2285.
223. Taberner F.J., Quilis I., Igual J.C. Spatial regulation of the start repressor Whi5. Cell Cycle 2009, 8:3010-3018.
224. Nakatsu Y., Sakoda H., Kushiyama A., Ono H., Fujishiro M., Horike N., Yoneda M., Ohno H., Tsuchiya Y., Kamata H., Tahara H., Isobe T., Nishimura F., Katagiri H., Oka Y., Fukushima T., Takahashi S., Kurihara H., Uchida T., Asano T. Pin1 associates with and induces translocation of CRTC2 to the cytosol, thereby suppressing cAMP-responsive element transcriptional activity. J. Biol. Chem. 2010, 285:33018-33027.
225. Pandit S., Wang D., Fu X.D. Functional integration of transcriptional and RNA processing machineries. Curr. Opin. Cell Biol. 2008, 20:260-265.
226. Winsor T.S., Bartkowiak B., Bennett C.B., Greenleaf A.L. A DNA damage response system associated with the phosphoCTD of elongating RNA polymerase II. PLoS One 2013, 8:e60909.
227. Steger M., Murina O., Huhn D., Ferretti L.P., Walser R., Hanggi K., Lafranchi L., Neugebauer C., Paliwal S., Janscak P., Gerrits B., Del Sal G., Zerbe O., Sartori A.A. Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection. Mol. Cell 2013, 50:333-343.
228. Jeong S.J., Kim H.J., Yang Y.J., Seol J.H., Jung B.Y., Han J.W., Lee H.W., Cho E.J. Role of RNA polymerase II carboxy terminal domain phosphorylation in DNA damage response. J. Microbiol. 2005, 43:516-522.
229. Sartori A.A., Steger M. Prolyl isomerization: a new PIN code for DSB repair. Cell Cycle 2013, 12:2717-2718.
230. Becker R., Loll B., Meinhart A. Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the carboxyl-terminal domain of RNA polymerase II. J. Biol. Chem. 2008, 283:22659-22669.
231. Li M., Phatnani H.P., Guan Z., Sage H., Greenleaf A.L., Zhou P. Solution structure of the Set2-Rpb1 interacting domain of human Set2 and its interaction with the hyperphosphorylated C-terminal domain of Rpb1. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:17636-17641.
232. Vojnic E., Simon B., Strahl B.D., Sattler M., Cramer P. Structure and carboxyl-terminal domain (CTD) binding of the Set2 SRI domain that couples histone H3 Lys36 methylation to transcription. J. Biol. Chem. 2006, 281:13-15.